Longitudinal follow up of serum anti-Müllerian hormone levels in women with rheumatoid arthritis

Longitudinal follow up of serum anti-Müllerian hormone levels in women with rheumatoid arthritis - AMH in RA

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42665

Enrollment

260

Registered

2015-09-17

Start date

2015-10-15

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis and ovarian ageing

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Women who participated in the PARA study (2002-2010): - a diagnosis of RA according to the ACR 1987 criteria - actively trying to conceive or pregnant at the time of enrolment in the PARA study - a good understanding of the Dutch language Available serum from preconceptional visits or the visit 26 weeks post partum in the PARA study.

Exclusion criteria

Exclusion criteria: Women who did not participate in the PARA study Women who are currently living outside the Netherlands or Belgium Women for whom no serum samples are available from the preconceptional visit or the visit 26 weeks after delivery during the PARA study

Design outcomes

Primary

Measure	Time frame
Serum anti-Müllerian hormone (AMH) levels	—

Countries

Netherlands

Outcome results